A major breakthrough has arrived in the March 2026 Liquid Biopsy Market, which is now valued at $14.23 billion. While previous years focused purely on detecting tumor DNA, 2026 has seen the launch of the first "AI-Powered Immune Intelligence" platforms. These 2026 systems do not just look for cancer cells; they analyze how a patient’s immune system is responding to the disease in...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
thai
English
French
Spanish
Portuguese
Italiano
Romaian
china